Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia

NCT02842112 · clinicaltrials.gov ↗

COMPLETED

Status

123

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

OTHER: PBSC mobilization and leukapheresis

Sponsor

Hospices Civils de Lyon